Friday, December 9, 2022


Leading Stem Cell Clinic in the US Develops First Real “Stem Cell Face Mask”

Springs Rejuvenation began as a Stem Cell and Exosome treatment center with a focus on acute medical conditions and joint injures. More recently the...

Jackie Veivia-Panter Joins BioCentriq as Chief Quality and Compliance Officer

BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced that Jackie Veivia-Panter is the new Chief Quality and Compliance...

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did not meet its primary endpoint in the Phase 2 STEAMBOAT™...

MaxCyte Signs Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options...

Hot Topics